Weight Management Drugs, Update from Coventry and Warwickshire ICB

NHS Weight Loss Drugs in Coventry and Warwickshire – What You Need to Know

From 23 June 2025, the NHS is beginning a phased rollout of the weight loss medication Tirzepatide (Mounjaro) for a limited group of eligible patients. The NHS is rolling out access to this medicine in phases to ensure fair and safe delivery to those most in clinical need and who will benefit the most from the treatment.

However, in Coventry and Warwickshire, this medication is not yet available as an option in managing obesity. We are currently developing a weight management service that will include access to weight loss medications alongside lifestyle support, accessible within the community. This service is expected to launch in autumn 2025.

Until this service is live, GPs cannot prescribe Tirzepatide for managing obesity. Even if you meet the national eligibility criteria, please do not request this medication at GP appointments as you will be contacted if you are eligible.

Full details available in the Coventry & Warwickshire ICB update, read more by clicking here.